Data as of Nov 21
| -0.29 / -0.30%|
Novartis AG develops, manufactures, and markets healthcare products. It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, Vaccines and Diagnostics, and Consumer Health. The Pharmaceuticals segment provides patent-protected prescription medicines. The Alcon segment offers surgical, ophthalmic pharmaceuticals, and vision care products. The Sandoz segment provides generic pharmaceuticals. The Vaccines and Diagnostics segment provides human vaccines and blood testing diagnostics. The Consumer Health segment contains two divisions, OTC and Animal Health. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
|Joseph Jimenez||Chief Executive Officer|
|Harry Kirsch||Chief Financial Officer|
|Jürgen Brokatzky-Geiger||Global Head-Corporate Responsibility|
|Jeff George||Member-Executive Board|
|Paul van Arkel||Head-Corporate Strategy & External Affairs|